Sol-gel technologies ltd to host virtual kol event on gorlin syndrome and the upcoming phase 3 trial for sgt-610

Ness ziona, israel, nov. 28, 2023 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl) (“sol-gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, twyneo® and epsolay®, today announced it will host a virtual kol event on wednesday, december 6, 2023 at 12:00 pm et. to register, click here .
SLGL Ratings Summary
SLGL Quant Ranking